Old Web
English
Sign In
Acemap
>
authorDetail
>
Mikael Eriksson
Mikael Eriksson
Karolinska University Hospital
Immunology
Medicine
Chemoimmunotherapy
Oncology
Internal medicine
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dose-dense chemoimmunotherapy and CNS prophylaxis in patients with high-risk DLBCL: a comparison of Nordic CRY-04 and CHIC studies
2017
ICML | International Conference on Machine Learning
Sirpa Leppä
J. Joergensen
Peter Brown
Unn-Merete Fagerli
Thomas Stauffer Larsen
R. Janes
Susanna Mannisto
Lars Munksgaard
Martin Maisenhölder
Kaija Vasala
Peter Meyer
Mats Jerkeman
Magnus Björkholm
Øystein Fluge
Sirkku Jyrkkiö
Lars Møller Pedersen
Mikael Eriksson
Harald Holte
Show All
Source
Cite
Save
Citations (0)
Lymphoma Group rescue: a nonrandomized phase 2 multicenter study by the Nordic purged stem cell - intensive front-line immunochemotherapy with in vivo Long-term progression-free survival of mantle cell lymphoma after
2013
Ruth Langholm
Jan Delabie
Marja-Liisa Karjalainen-Lindsberg
Peter de Nully Brown
Herman Nilsson-Ehle
M. Åkerman
Mats Ehinger
Mikael Eriksson
Marie Nordström
Eva Kimby
Anne Marie Boesen
Outi Kuittinen
Christian H. Geisler
Arne Kolstad
Anna Laurell
Niels S. Andersen
Lone Bredo Pedersen
Show All
Source
Cite
Save
Citations (0)
R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2–3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18- 64 Years
2008
Blood
H. Holte
Sirpa Leppä
Magnus Björkholm
Oystein Fluge
Sirkku Jyrkkiö
Jan Delabie
Christer Sundström
Marja-Liisa Karjalainen-Lindsberg
Martin Erlanson
Arne Kolstad
Alexander Fosså
Bjørn Østenstad
Eva Löfvenberg
Marie Nordstroem
Lars Moller-Pedersen
Harald Anderson
Mats Jerkeman
Mikael Eriksson
Show All
Source
Cite
Save
Citations (0)
1